SKK
ADMS

Shepherd Kaplan Krochuk’s Adamas Pharmaceuticals ADMS Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-12,221
Closed -$201K – 365
2016
Q3 		$201K Hold
12,221
– – 0.04% 243
2016
Q2 		$185K Hold
12,221
– – 0.05% 245
2016
Q1 		$177K Sell
12,221
-4,073
-25% -$68.6K 0.05% 210
2015
Q4 		$461K Hold
16,294
– – 0.12% 122
2015
Q3 		$273K Hold
16,294
– – 0.07% 198
2015
Q2 		$427K Hold
16,294
– – 0.08% 193
2015
Q1 		$285K Buy
+16,294
New +$279K 0.05% 243

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Shepherd Kaplan Krochuk's ADMS Position: Q4 2016 in Review

Shepherd Kaplan Krochuk sold out of Adamas Pharmaceuticals (ADMS) in Q4 2016, closing a stake of 12,221 shares — an estimated $201K sold.

Shepherd Kaplan Krochuk first reported a position in ADMS in Q1 2015 and held it in 7 quarters. The position peaked at $461K in Q4 2015. 78 funds tracked by Wall St. Rank hold ADMS as of Q4 2016.

  • Shepherd Kaplan Krochuk reported no remaining Adamas Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 12,221 Adamas Pharmaceuticals shares in Q4 2016, an estimated $201K.
  • Shepherd Kaplan Krochuk first reported a position in Adamas Pharmaceuticals in Q1 2015 and held it in 7 quarters.
  • Shepherd Kaplan Krochuk's Adamas Pharmaceuticals position peaked at $461K in Q4 2015.
  • 78 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2016.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2016, filed 10 Feb 2017.